IL18 and ulcerative colitis: They proposed that a strict equilibrium of epithelial IL-18 signaling must be maintained and suggested that IL-18 targeting may prevent the pathologic breakdown of the mucosal barrier in human ulcerative colitis (Nowarski et al., 2015) [68].